Approaches to dimensionality reduction in proteomic biomarker studies - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Mar;9(2):102-18.
doi: 10.1093/bib/bbn005. Epub 2008 Feb 29.

Approaches to dimensionality reduction in proteomic biomarker studies

Affiliations
Review

Approaches to dimensionality reduction in proteomic biomarker studies

Melanie Hilario et al. Brief Bioinform. 2008 Mar.

Abstract

Mass-spectra based proteomic profiles have received widespread attention as potential tools for biomarker discovery and early disease diagnosis. A major data-analytical problem involved is the extremely high dimensionality (i.e. number of features or variables) of proteomic data, in particular when the sample size is small. This article reviews dimensionality reduction methods that have been used in proteomic biomarker studies. It then focuses on the problem of selecting the most appropriate method for a specific task or dataset, and proposes method combination as a potential alternative to single-method selection. Finally, it points out the potential of novel dimension reduction techniques, in particular those that incorporate domain knowledge through the use of informative priors or causal inference.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources